Market Cap | ₹4,591Cr |
ROE | 7.19% |
P/E Ratio(TTM) | 50.59 |
EPS(TTM) | 7.36 |
P/B Ratio | 3.64 |
Dividend Yield | 0.38% |
Industry P/E | 34.13 |
Book Value | 102.37 |
Debt to Equity | 0.61 |
Face Value | 2 |
Parent Organisation | Hikal Limited |
Managing Director | Mr. Sameer Hiremath |
NSE Symbol | HIKAL |
FUND NAME | AUM(%) |
---|---|
Tata Small Cap Fund Direct Growth | 1.36% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 79.38 | ||
Jubilant Pharmova | NA (0.00%) | 21.63 | ||
Neuland Laboratories | NA (0.00%) | 64.31 | ||
Acutaas Chemicals | NA (0.00%) | 58.84 |